中文版 | English
题名

Characterizing the cellular and molecular variabilities of peripheral immune cells in healthy recipients of BBIBP-CorV inactivated SARS-CoV-2 vaccine by single-cell RNA sequencing

作者
通讯作者Wang, Feng; Pu, Jun
发表日期
2023-12-31
DOI
发表期刊
EISSN
2222-1751
卷号12期号:1
摘要
Over 3 billion doses of inactivated vaccines for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have been administered globally. However, our understanding of the immune cell functional transcription and T cell receptor (TCR)/B cell receptor (BCR) repertoire dynamics following inactivated SARS-CoV-2 vaccination remains poorly understood. Here, we performed single-cell RNA and TCR/BCR sequencing on peripheral blood mononuclear cells at four time points after immunization with the inactivated SARS-CoV-2 vaccine BBIBP-CorV. Our analysis revealed an enrichment of monocytes, central memory CD4(+) T cells, type 2 helper T cells and memory B cells following vaccination. Single-cell TCR-seq and RNA-seq comminating analysis identified a clonal expansion of CD4(+) T cells (but not CD8(+) T cells) following a booster vaccination that corresponded to a decrease in the TCR diversity of central memory CD4(+) T cells and type 2 helper T cells. Importantly, these TCR repertoire changes and CD4(+) T cell differentiation were correlated with the biased VJ gene usage of BCR and the antibody-producing function of B cells post-vaccination. Finally, we compared the functional transcription and repertoire dynamics in immune cells elicited by vaccination and SARS-CoV-2 infection to explore the immune responses under different stimuli. Our data provide novel molecular and cellular evidence for the CD4(+) T cell-dependent antibody response induced by inactivated vaccine BBIBP-CorV. This information is urgently needed to develop new prevention and control strategies for SARS-CoV-2 infection. (ClinicalTrials.gov Identifier: NCT04871932).
关键词
相关链接[来源记录]
收录类别
语种
英语
学校署名
其他
WOS研究方向
Immunology ; Infectious Diseases ; Microbiology
WOS类目
Immunology ; Infectious Diseases ; Microbiology
WOS记录号
WOS:000983598100001
出版者
来源库
Web of Science
引用统计
被引频次[WOS]:3
成果类型期刊论文
条目标识符http://sustech.caswiz.com/handle/2SGJ60CL/536284
专题南方科技大学医学院
南方科技大学第一附属医院
南方科技大学第二附属医院
作者单位
1.Shanghai Jiao Tong Univ, Renji Hosp, Shanghai Immune Therapy Inst, Sch Med,Div Cardiol, Shanghai, Peoples R China
2.Shanghai Jiao Tong Univ, Shanghai Inst Immunol, Sch Med, Dept Immunol & Microbiol,State Key Lab Oncogenes &, Shanghai, Peoples R China
3.Southern Univ Sci & Technol, Shenzhen Peoples Hosp 3, Affiliated Hosp 2, Sch Med,Natl Clin Res Ctr Infect Dis,Inst Hepatolo, Shenzhen, Peoples R China
4.Shanghai Jiao Tong Univ, Sch Biomed Engn, Shanghai, Peoples R China
5.Shanghai Jiao Tong Univ, Med X Res Inst, Shanghai, Peoples R China
6.Shanghai Jiao Tong Univ, Xinhua Hosp, Inst Dev & Regenerat Cardiovasc Med, Sch Med, Shanghai, Peoples R China
推荐引用方式
GB/T 7714
Tong, Renyang,Luo, Lingjie,Zhao, Yichao,et al. Characterizing the cellular and molecular variabilities of peripheral immune cells in healthy recipients of BBIBP-CorV inactivated SARS-CoV-2 vaccine by single-cell RNA sequencing[J]. EMERGING MICROBES & INFECTIONS,2023,12(1).
APA
Tong, Renyang.,Luo, Lingjie.,Zhao, Yichao.,Sun, Mingze.,Li, Ronghong.,...&Pu, Jun.(2023).Characterizing the cellular and molecular variabilities of peripheral immune cells in healthy recipients of BBIBP-CorV inactivated SARS-CoV-2 vaccine by single-cell RNA sequencing.EMERGING MICROBES & INFECTIONS,12(1).
MLA
Tong, Renyang,et al."Characterizing the cellular and molecular variabilities of peripheral immune cells in healthy recipients of BBIBP-CorV inactivated SARS-CoV-2 vaccine by single-cell RNA sequencing".EMERGING MICROBES & INFECTIONS 12.1(2023).
条目包含的文件
条目无相关文件。
个性服务
原文链接
推荐该条目
保存到收藏夹
查看访问统计
导出为Endnote文件
导出为Excel格式
导出为Csv格式
Altmetrics Score
谷歌学术
谷歌学术中相似的文章
[Tong, Renyang]的文章
[Luo, Lingjie]的文章
[Zhao, Yichao]的文章
百度学术
百度学术中相似的文章
[Tong, Renyang]的文章
[Luo, Lingjie]的文章
[Zhao, Yichao]的文章
必应学术
必应学术中相似的文章
[Tong, Renyang]的文章
[Luo, Lingjie]的文章
[Zhao, Yichao]的文章
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
[发表评论/异议/意见]
暂无评论

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。